Intravenous metoprolol and cardiac dysrhythmias. An evaluation in the management of dysrhythmias in outpatient dental anaesthesia.
The use of intravenous metoprolol in a dose of 0.06--0.17 mg/kg body weight proved effective in the treatment of sinus tachycardia in excess of 150 beats/min and/or ventricular dysrhythmias associated with light halothane anaesthesia for outpatient dental surgery. There were no side-effects related to this cardioselective beta-blocker in the dosage used. The prophylactic use of oral metoprolol should be considered for patients who find the prospect of dental treatment a fearsome experience.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000556:Ambulatory Surgical Procedures; D000766:Anesthesia, Dental / Q000009:adverse effects*; D000768:Anesthesia, General / Q000009:adverse effects*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000209:etiology; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008790:Metoprolol / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D011412:Propanolamines / Q000627:therapeutic use*; D013610:Tachycardia / Q000188:drug therapy / Q000209:etiology
D011412:Propanolamines; D008790:Metoprolol